NEW: No-Cost StreetSmart Live! Events. This type of intellectual capital is usually not made available to the general public. Learn More

Sector Expert: Shane Matte

BioTuesdays



Recent Quotes

"RP has successfully completed its first-in-human clinical study of the company's autologous cell therapy for the treatment of androgenetic alopecia."

— Shane Matte, BioTuesdays (3/14/17)
more >

"The validation program for DXD's Hodgkin's lymphoma test (Telo-HL) is under way."

— Shane Matte, BioTuesdays (2/23/17)
more >



Due to permission requirements, not all quotes are shown.